{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:07:29Z","timestamp":1793639249132,"version":"4.5.1"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T00:00:00Z","timestamp":1452902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12016-016-8527-x","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T18:11:18Z","timestamp":1452967878000},"page":"58-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review"],"prefix":"10.1007","volume":"52","author":[{"given":"Angela","family":"Ceribelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Isailovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"key":"8527_CR1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40265-014-0240-6","volume":"74","author":"T Hornung","year":"2014","unstructured":"Hornung T, Wenzel J (2014) Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment. Drugs 74:981\u2013998","journal-title":"Drugs"},{"key":"8527_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/mus.21669","volume":"41","author":"S Khanna","year":"2010","unstructured":"Khanna S, Reed AM (2010) Immunopathogenesis of juvenile dermatomyositis. Muscle Nerve 41:581\u2013592","journal-title":"Muscle Nerve"},{"key":"8527_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rdc.2011.01.002","volume":"37","author":"K Nagaraju","year":"2011","unstructured":"Nagaraju K, Lundberg IE (2011) Polymyositis and dermatomyositis: pathophysiology. Rheum Dis Clin N Am 37:159\u2013171, v","journal-title":"Rheum Dis Clin N Am"},{"key":"8527_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","volume":"64","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Kastner DL, Remmers EF (2015) The immunogenetics of Behcet\u2019s disease: a comprehensive review. J Autoimmun 64:137\u2013148","journal-title":"J Autoimmun"},{"key":"8527_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaut.2015.08.004","volume":"64","author":"Y Ghodke-Puranik","year":"2015","unstructured":"Ghodke-Puranik Y, Niewold TB (2015) Immunogenetics of systemic lupus erythematosus: a comprehensive review. J Autoimmun 64:125\u2013136","journal-title":"J Autoimmun"},{"key":"8527_CR6","doi-asserted-by":"crossref","unstructured":"Ahmadian-Elmi M, Bidmeshki Pour A, Naghavian R, Ghaedi K, Tanhaei S, Izadi T et al. (2015) miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4 T lymphocytes of patients with relapsing-remitting multiple sclerosis. Immunogenetics","DOI":"10.1007\/s00251-015-0881-y"},{"key":"8527_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2015.08.002","volume":"64","author":"AO Hersh","year":"2015","unstructured":"Hersh AO, Prahalad S (2015) Immunogenetics of juvenile idiopathic arthritis: a comprehensive review. J Autoimmun 64:113\u2013124","journal-title":"J Autoimmun"},{"key":"8527_CR8","doi-asserted-by":"crossref","first-page":"8820","DOI":"10.1038\/ncomms9820","volume":"6","author":"T Yanagihara","year":"2015","unstructured":"Yanagihara T, Sanematsu F, Sato T, Uruno T, Duan X, Tomino T et al (2015) Intronic regulation of Aire expression by Jmjd6 for self-tolerance induction in the thymus. Nat Commun 6:8820","journal-title":"Nat Commun"},{"key":"8527_CR9","doi-asserted-by":"crossref","unstructured":"Barkia Beradhi S, Flesch BK, Hansen MP, Matheis N, Kahaly GJ (2015) HLA class II differentiates between thyroid and polyglandular autoimmunity. Horm Metab Res","DOI":"10.1055\/s-0035-1559622"},{"key":"8527_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","volume":"64","author":"JA Noble","year":"2015","unstructured":"Noble JA (2015) Immunogenetics of type 1 diabetes: a comprehensive review. J Autoimmun 64:101\u2013112","journal-title":"J Autoimmun"},{"key":"8527_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaut.2015.07.013","volume":"64","author":"KM Lange de","year":"2015","unstructured":"de Lange KM, Barrett JC (2015) Understanding inflammatory bowel disease via immunogenetics. J Autoimmun 64:91\u2013100","journal-title":"J Autoimmun"},{"key":"8527_CR12","doi-asserted-by":"crossref","unstructured":"Webb GJ, Hirschfield GM (2015) Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun","DOI":"10.1016\/j.jaut.2015.08.016"},{"key":"8527_CR13","first-page":"434","volume":"48","author":"A Pontillo","year":"2015","unstructured":"Pontillo A, Reis EC, Liphaus BL, Silva CA, Carneiro-Sampaio M (2015) Inflammasome polymorphisms in juvenile systemic lupus erythematosus. Autoimmunity 48:434\u2013437","journal-title":"Autoimmunity"},{"key":"8527_CR14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ajhg.2015.03.002","volume":"96","author":"X Lu","year":"2015","unstructured":"Lu X, Zoller EE, Weirauch MT, Wu Z, Namjou B, Williams AH et al (2015) Lupus risk variant increases pSTAT1 binding and decreases ETS1 expression. Am J Hum Genet 96:731\u2013739","journal-title":"Am J Hum Genet"},{"key":"8527_CR15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","volume":"64","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y (2015) Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun 64:82\u201390","journal-title":"J Autoimmun"},{"key":"8527_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2015.07.007","volume":"64","author":"TC Messemaker","year":"2015","unstructured":"Messemaker TC, Huizinga TW, Kurreeman F (2015) Immunogenetics of rheumatoid arthritis: understanding functional implications. J Autoimmun 64:74\u201381","journal-title":"J Autoimmun"},{"key":"8527_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","volume":"64","author":"JL Harden","year":"2015","unstructured":"Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of psoriasis: a comprehensive review. J Autoimmun 64:66\u201373","journal-title":"J Autoimmun"},{"key":"8527_CR18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1126\/science.1260791","volume":"345","author":"F Rieux-Laucat","year":"2014","unstructured":"Rieux-Laucat F, Casanova JL (2014) Immunology. Autoimmunity by haploinsufficiency. Science 345:1560\u20131561","journal-title":"Science"},{"key":"8527_CR19","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1210\/jc.2013-2852","volume":"99","author":"BK Flesch","year":"2014","unstructured":"Flesch BK, Matheis N, Alt T, Weinstock C, Bux J, Kahaly GJ (2014) HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III. J Clin Endocrinol Metab 99:E177\u2013E182","journal-title":"J Clin Endocrinol Metab"},{"key":"8527_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2015.07.005","volume":"64","author":"L Bossini-Castillo","year":"2015","unstructured":"Bossini-Castillo L, Lopez-Isac E, Martin J (2015) Immunogenetics of systemic sclerosis: defining heritability, functional variants and shared-autoimmunity pathways. J Autoimmun 64:53\u201365","journal-title":"J Autoimmun"},{"key":"8527_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","volume":"64","author":"JA Hollenbach","year":"2015","unstructured":"Hollenbach JA, Oksenberg JR (2015) The immunogenetics of multiple sclerosis: a comprehensive review. J Autoimmun 64:13\u201325","journal-title":"J Autoimmun"},{"key":"8527_CR22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/cmi.2010.78","volume":"8","author":"F Meda","year":"2011","unstructured":"Meda F, Folci M, Baccarelli A, Selmi C (2011) The epigenetics of autoimmunity. Cell Mol Imunol 8:226\u2013236","journal-title":"Cell Mol Imunol"},{"key":"8527_CR23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaut.2012.07.011","volume":"39","author":"C Selmi","year":"2012","unstructured":"Selmi C, Lu Q, Humble MC (2012) Heritability versus the role of the environment in autoimmunity. J Autoimmun 39:249\u2013252","journal-title":"J Autoimmun"},{"key":"8527_CR24","doi-asserted-by":"crossref","first-page":"A247","DOI":"10.1016\/j.autrev.2010.02.004","volume":"9","author":"C Selmi","year":"2010","unstructured":"Selmi C (2010) The worldwide gradient of autoimmune conditions. Autoimmun Rev 9:A247\u2013A250","journal-title":"Autoimmun Rev"},{"key":"8527_CR25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaut.2012.05.001","volume":"39","author":"FW Miller","year":"2012","unstructured":"Miller FW, Pollard KM, Parks CG, Germolec DR, Leung PS, Selmi C et al (2012) Criteria for environmentally associated autoimmune diseases. J Autoimmun 39:253\u2013258","journal-title":"J Autoimmun"},{"key":"8527_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/ar3739","volume":"14","author":"M Satoh","year":"2012","unstructured":"Satoh M, Ceribelli A, Chan EK (2012) Role of environmental factors in autoantibody production\u2014importance of a detailed analysis in a small cohort. Arthritis Res Ther 14:109","journal-title":"Arthritis Res Ther"},{"key":"8527_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1196\/annals.1423.003","volume":"1110","author":"K Kikuchi","year":"2007","unstructured":"Kikuchi K, Tanaka A, Matsushita M, Kitazawa E, Hosoya N, Kawashima Y et al (2007) Genetic polymorphisms of transforming growth factor beta-1 promoter and primary biliary cirrhosis in Japanese patients. Ann N Y Acad Sci 1110:15\u201322","journal-title":"Ann N Y Acad Sci"},{"key":"8527_CR28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.22102","volume":"47","author":"S Shimoda","year":"2008","unstructured":"Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A et al (2008) Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatol (Baltimore, MD) 47:958\u2013965","journal-title":"Hepatol (Baltimore, MD)"},{"key":"8527_CR29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059835","volume":"8","author":"S Ringquist","year":"2013","unstructured":"Ringquist S, Bellone G, Lu Y, Roeder K, Trucco M (2013) Clustering and alignment of polymorphic sequences for HLA-DRB1 genotyping. PLoS One 8, e59835","journal-title":"PLoS One"},{"key":"8527_CR30","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/art.11090","volume":"48","author":"S Okada","year":"2003","unstructured":"Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW (2003) Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 48:2285\u20132293","journal-title":"Arthritis Rheum"},{"key":"8527_CR31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/BOR.0b013e328331638a","volume":"21","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, McHugh NJ (2009) Pathogenic mechanisms of disease in myositis: autoantigens as clues. Curr Opin Rheumatol 21:604\u2013609","journal-title":"Curr Opin Rheumatol"},{"key":"8527_CR32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00296-007-0485-4","volume":"28","author":"A Altman","year":"2008","unstructured":"Altman A, Szyper-Kravitz M, Shoenfeld Y (2008) HBV vaccine and dermatomyositis: is there an association? Rheumatol Int 28:609\u2013612","journal-title":"Rheumatol Int"},{"key":"8527_CR33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1177\/0961203309345734","volume":"18","author":"H Orbach","year":"2009","unstructured":"Orbach H, Tanay A (2009) Vaccines as a trigger for myopathies. Lupus 18:1213\u20131216","journal-title":"Lupus"},{"key":"8527_CR34","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(78)90885-1","volume":"1","author":"E Kass","year":"1978","unstructured":"Kass E, Straume S, Munthe E (1978) Dermatomyositis after B.C.G. vaccination. Lancet 1:772","journal-title":"Lancet"},{"key":"8527_CR35","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archinte.1983.00350070177026","volume":"143","author":"JM Albert","year":"1983","unstructured":"Albert JM, Ott HJ (1983) Calcifying dermatomyositis following antitetanus vaccination. Arch Intern Med 143:1457\u20131458","journal-title":"Arch Intern Med"},{"issue":"Suppl","key":"8527_CR36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","volume":"25","author":"JF Bach","year":"2005","unstructured":"Bach JF (2005) Infections and autoimmune diseases. J Autoimmun 25(Suppl):74\u201380","journal-title":"J Autoimmun"},{"key":"8527_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","volume":"64","author":"AL Mammen","year":"2012","unstructured":"Mammen AL, Pak K, Williams EK, Brisson D, Coresh J, Selvin E et al (2012) Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res 64:269\u2013272","journal-title":"Arthritis Care Res"},{"key":"8527_CR38","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0b013e32830e2774","volume":"21","author":"T Klopstock","year":"2008","unstructured":"Klopstock T (2008) Drug-induced myopathies. Curr Opin Neurol 21:590\u2013595","journal-title":"Curr Opin Neurol"},{"key":"8527_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2230.2005.01934.x","volume":"31","author":"MJ Arin","year":"2006","unstructured":"Arin MJ, Scheid C, Hubel K, Krieg T, Groth W, Haerrmann G (2006) Chronic graft-versus-host disease with skin signs suggestive of dermatomyositis. Clin Exp Dermatol 31:141\u2013143","journal-title":"Clin Exp Dermatol"},{"key":"8527_CR40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.7326\/0003-4819-118-12-199306150-00002","volume":"118","author":"J Cukier","year":"1993","unstructured":"Cukier J, Beauchamp RA, Spindler JS, Spindler S, Lorenzo C, Trentham DE (1993) Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med 118:920\u2013928","journal-title":"Ann Intern Med"},{"key":"8527_CR41","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/art.21198","volume":"52","author":"K Sarkar","year":"2005","unstructured":"Sarkar K, Weinberg CR, Oddis CV, Medsger TA Jr, Plotz PH, Reveille JD et al (2005) Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum 52:2433\u20132438","journal-title":"Arthritis Rheum"},{"key":"8527_CR42","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/art.1780341108","volume":"34","author":"RL Leff","year":"1991","unstructured":"Leff RL, Burgess SH, Miller FW, Love LA, Targoff IN, Dalakas MC et al (1991) Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum 34:1391\u20131396","journal-title":"Arthritis Rheum"},{"key":"8527_CR43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02918552","volume":"8","author":"RS Fujinami","year":"1989","unstructured":"Fujinami RS, Oldstone MB (1989) Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res 8:3\u201315","journal-title":"Immunol Res"},{"key":"8527_CR44","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","volume":"12","author":"MB Oldstone","year":"1998","unstructured":"Oldstone MB (1998) Molecular mimicry and immune-mediated diseases. Faseb J 12:1255\u20131265","journal-title":"Faseb J"},{"key":"8527_CR45","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R et al (2005) Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 52:1824\u20131835","journal-title":"Arthritis Rheum"},{"key":"8527_CR46","first-page":"2691","volume":"26","author":"S Plamondon","year":"1999","unstructured":"Plamondon S, Dent PB, Reed AM (1999) Familial dermatomyositis. J Rheumatol 26:2691\u20132692","journal-title":"J Rheumatol"},{"key":"8527_CR47","doi-asserted-by":"crossref","first-page":"J156","DOI":"10.1016\/j.jaut.2011.11.003","volume":"38","author":"DP Bogdanos","year":"2012","unstructured":"Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38:J156\u2013J169","journal-title":"J Autoimmun"},{"key":"8527_CR48","first-page":"1981","volume":"23","author":"PN Malleson","year":"1996","unstructured":"Malleson PN, Fung MY, Rosenberg AM (1996) The incidence of pediatric rheumatic diseases: results from the canadian pediatric rheumatology association disease registry. J Rheumatol 23:1981\u20131987","journal-title":"J Rheumatol"},{"key":"8527_CR49","doi-asserted-by":"crossref","first-page":"A330","DOI":"10.1016\/j.autrev.2009.11.006","volume":"9","author":"S Prieto","year":"2010","unstructured":"Prieto S, Grau JM (2010) The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 9:A330\u2013A334","journal-title":"Autoimmun Rev"},{"key":"8527_CR50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08916930600622348","volume":"39","author":"S Zampieri","year":"2006","unstructured":"Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Atzeni F et al (2006) Polymyositis-dermatomyositis and infections. Autoimmunity 39:191\u2013196","journal-title":"Autoimmunity"},{"key":"8527_CR51","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1172\/JCI24646","volume":"115","author":"P Soulas","year":"2005","unstructured":"Soulas P, Woods A, Jaulhac B, Knapp AM, Pasquali JL, Martin T et al (2005) Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection. J Clin Invest 115:2257\u20132267","journal-title":"J Clin Invest"},{"key":"8527_CR52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1462-5822.2004.00408.x","volume":"6","author":"F Winau","year":"2004","unstructured":"Winau F, Kaufmann SH, Schaible UE (2004) Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria. Cell Microbiol 6:599\u2013607","journal-title":"Cell Microbiol"},{"key":"8527_CR53","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.coi.2005.09.018","volume":"17","author":"JA Mahoney","year":"2005","unstructured":"Mahoney JA, Rosen A (2005) Apoptosis and autoimmunity. Curr Opin Immunol 17:583\u2013588","journal-title":"Curr Opin Immunol"},{"key":"8527_CR54","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RHU.0b013e318268566c","volume":"18","author":"A Rajadhyaksha","year":"2012","unstructured":"Rajadhyaksha A, Baheti TG, Mehra S, Sonawale AS, Jain N (2012) Dermatomyositis: a rare presentation of HIV seroconversion illness. J Clin Rheumatol:Pract Rep Rheumatic Musculoskelet Dis 18:298\u2013300","journal-title":"J Clin Rheumatol:Pract Rep Rheumatic Musculoskelet Dis"},{"key":"8527_CR55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.autrev.2013.08.005","volume":"13","author":"JP Stubgen","year":"2014","unstructured":"Stubgen JP (2014) A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev 13:31\u201339","journal-title":"Autoimmun Rev"},{"key":"8527_CR56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000110224","volume":"4","author":"EM Kurland","year":"1985","unstructured":"Kurland EM, Kurland LT, Mulder DW, Kirkpatrick J, Helmkamp JC (1985) Lack of association of A\/NJ\/76 (swine flu) vaccine and polymyositis. Neuroepidemiology 4:125\u2013137","journal-title":"Neuroepidemiology"},{"key":"8527_CR57","first-page":"e45","volume":"14","author":"BC Carleton","year":"2007","unstructured":"Carleton BC, Smith MA, Gelin MN, Heathcote SC (2007) Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol=J Can Pharmacol Clin 14:e45\u2013e57","journal-title":"Can J Clin Pharmacol=J Can Pharmacol Clin"},{"key":"8527_CR58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12016-013-8401-z","volume":"47","author":"Y Saito","year":"2014","unstructured":"Saito Y, Saito H, Liang G, Friedman JM (2014) Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol 47:128\u2013135","journal-title":"Clin Rev Allergy Immunol"},{"key":"8527_CR59","doi-asserted-by":"crossref","unstructured":"Bao Y, Cao X (2015) Epigenetic control of B cell development and B-cell-related immune disorders. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-015-8494-7"},{"key":"8527_CR60","doi-asserted-by":"crossref","unstructured":"Liang Y, Chang C, Lu Q (2015) The genetics and epigenetics of atopic dermatitis-filaggrin and other polymorphisms. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-015-8508-5"},{"key":"8527_CR61","doi-asserted-by":"crossref","unstructured":"Meroni PL, Penatti AE (2015) Epigenetics and systemic lupus erythematosus: unmet needs. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-015-8497-4"},{"key":"8527_CR62","doi-asserted-by":"crossref","unstructured":"Renauer P, Coit P, Sawalha AH (2015) epigenetics and vasculitis: a comprehensive review. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-015-8495-6"},{"key":"8527_CR63","doi-asserted-by":"crossref","unstructured":"Xie YQ, Ma HD, Lian ZX (2015) Epigenetics and primary biliary cirrhosis: a comprehensive review and implications for autoimmunity. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-015-8502-y"},{"key":"8527_CR64","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.humimm.2005.10.002","volume":"66","author":"N Dhiman","year":"2005","unstructured":"Dhiman N, Ovsyannikova IG, Oberg AL, Grill DE, Jacobson RM, Poland GA (2005) Immune activation at effector and gene expression levels after measles vaccination in healthy individuals: a pilot study. Hum Immunol 66:1125\u20131136","journal-title":"Hum Immunol"},{"key":"8527_CR65","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1261\/rna.7207205","volume":"11","author":"H Liang","year":"2005","unstructured":"Liang H, Landweber LF (2005) Molecular mimicry: quantitative methods to study structural similarity between protein and RNA. RNA 11:1167\u20131172","journal-title":"RNA"},{"key":"8527_CR66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/ard.59.2.141","volume":"59","author":"GJ Hengstman","year":"2000","unstructured":"Hengstman GJ, van Venrooij WJ, Vencovsky J, Moutsopoulos HM, van Engelen BG (2000) The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient. Ann Rheum Dis 59:141\u2013142","journal-title":"Ann Rheum Dis"},{"key":"8527_CR67","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","volume":"74","author":"C Dobloug","year":"2015","unstructured":"Dobloug C, Garen T, Bitter H, Stjarne J, Stenseth G, Grovle L et al (2015) Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis 74:1551\u20131556","journal-title":"Ann Rheum Dis"},{"key":"8527_CR68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendewald","year":"2010","unstructured":"Bendewald MJ, Wetter DA, Li X, Davis MD (2010) Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol 146:26\u201330","journal-title":"Arch Dermatol"},{"key":"8527_CR69","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/ard.2008.093161","volume":"68","author":"S Bernatsky","year":"2009","unstructured":"Bernatsky S, Joseph L, Pineau CA, Belisle P, Boivin JF, Banerjee D et al (2009) Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 68:1192\u20131196","journal-title":"Ann Rheum Dis"},{"key":"8527_CR70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-13-103","volume":"13","author":"KE Smoyer-Tomic","year":"2012","unstructured":"Smoyer-Tomic KE, Amato AA, Fernandes AW (2012) Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis. BMC Musculoskelet Disord 13:103","journal-title":"BMC Musculoskelet Disord"},{"key":"8527_CR71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/14397595.2013.844308","volume":"24","author":"A Ohta","year":"2014","unstructured":"Ohta A, Nagai M, Nishina M, Tomimitsu H, Kohsaka H (2014) Prevalence and incidence of polymyositis and dermatomyositis in Japan. Modern Rheumatol Jpn Rheumatism Assoc 24:477\u2013480","journal-title":"Modern Rheumatol Jpn Rheumatism Assoc"},{"key":"8527_CR72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12016-015-8479-6","volume":"49","author":"G Rossi","year":"2015","unstructured":"Rossi G, Cavazza A, Colby TV (2015) Pathology of sarcoidosis. Clin Rev Allergy Immunol 49:36\u201344","journal-title":"Clin Rev Allergy Immunol"},{"key":"8527_CR73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12016-015-8478-7","volume":"49","author":"M Silva","year":"2015","unstructured":"Silva M, Nunes H, Valeyre D, Sverzellati N (2015) Imaging of sarcoidosis. Clin Rev Allergy Immunol 49:45\u201353","journal-title":"Clin Rev Allergy Immunol"},{"key":"8527_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8480-0","volume":"49","author":"P Spagnolo","year":"2015","unstructured":"Spagnolo P (2015) Sarcoidosis: a critical review of history and milestones. Clin Rev Allergy Immunol 49:1\u20135","journal-title":"Clin Rev Allergy Immunol"},{"key":"8527_CR75","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12016-015-8475-x","volume":"49","author":"TE Wessendorf","year":"2015","unstructured":"Wessendorf TE, Bonella F, Costabel U (2015) Diagnosis of sarcoidosis. Clin Rev Allergy Immunol 49:54\u201362","journal-title":"Clin Rev Allergy Immunol"},{"key":"8527_CR76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-014-8425-z","volume":"49","author":"Y Ozyazgan","year":"2015","unstructured":"Ozyazgan Y, Ucar D, Hatemi G, Yazici Y (2015) Ocular involvement of Behcet\u2019s syndrome: a comprehensive review. Clin Rev Allergy Immunol 49:298\u2013306","journal-title":"Clin Rev Allergy Immunol"},{"key":"8527_CR77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","volume":"62","author":"H Vallet","year":"2015","unstructured":"Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O et al (2015) Efficacy of anti-TNF alpha in severe and\/or refractory Behcet\u2019s disease: multicenter study of 124 patients. J Autoimmun 62:67\u201374","journal-title":"J Autoimmun"},{"key":"8527_CR78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2014.01.014","volume":"48\u201349","author":"H Yazici","year":"2014","unstructured":"Yazici H, Yazici Y (2014) Criteria for Behcet\u2019s disease with reflections on all disease criteria. J Autoimmun 48\u201349:104\u2013107","journal-title":"J Autoimmun"},{"key":"8527_CR79","doi-asserted-by":"crossref","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK (2015) A Comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-015-8510-y"},{"key":"8527_CR80","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12016-014-8424-0","volume":"47","author":"MG Zavala-Cerna","year":"2014","unstructured":"Zavala-Cerna MG, Martinez-Garcia EA, Torres-Bugarin O, Rubio-Jurado B, Riebeling C, Nava A (2014) The clinical significance of posttranslational modification of autoantigens. Clin Rev Allergy Immunol 47:73\u201390","journal-title":"Clin Rev Allergy Immunol"},{"key":"8527_CR81","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12016-015-8471-1","volume":"48","author":"Y Sun","year":"2015","unstructured":"Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin ME (2015) The coexistence of Sjogren\u2019s syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol 48:301\u2013315","journal-title":"Clin Rev Allergy Immunol"},{"key":"8527_CR82","first-page":"307","volume":"14","author":"R Gonzalez-Amaro","year":"1987","unstructured":"Gonzalez-Amaro R, Alcocer-Varela J, Alarcon-Segovia D (1987) Natural killer cell activity in dermatomyositis-polymyositis. J Rheumatol 14:307\u2013310","journal-title":"J Rheumatol"},{"key":"8527_CR83","first-page":"521","volume":"140","author":"H Noguchi","year":"1992","unstructured":"Noguchi H, Kephart GM, Colby TV, Gleich GJ (1992) Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 140:521\u2013528","journal-title":"Am J Pathol"},{"key":"8527_CR84","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20833","volume":"59","author":"M Krahn","year":"2006","unstructured":"Krahn M, Lopez de Munain A, Streichenberger N, Bernard R, Pecheux C, Testard H et al (2006) CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann Neurol 59:905\u2013911","journal-title":"Ann Neurol"},{"key":"8527_CR85","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0404.1996.tb07039.x","volume":"94","author":"T Kumamoto","year":"1996","unstructured":"Kumamoto T, Ueyama H, Fujimoto S, Nagao S, Tsuda T (1996) Clinicopathologic characteristics of polymyositis patients with numerous tissue eosinophils. Acta Neurol Scand 94:110\u2013114","journal-title":"Acta Neurol Scand"},{"key":"8527_CR86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/cei.12407","volume":"178","author":"K Fujikawa","year":"2014","unstructured":"Fujikawa K, Migita K, Shigemitsu Y, Umeda M, Nonaka F, Tamai M et al (2014) MEFV gene polymorphisms and TNFRSF1A mutation in patients with inflammatory myopathy with abundant macrophages. Clin Exp Immunol 178:224\u2013228","journal-title":"Clin Exp Immunol"},{"key":"8527_CR87","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.11428","volume":"50","author":"G Page","year":"2004","unstructured":"Page G, Chevrel G, Miossec P (2004) Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum 50:199\u2013208","journal-title":"Arthritis Rheum"},{"key":"8527_CR88","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","volume":"56","author":"ML Eloranta","year":"2007","unstructured":"Eloranta ML, Barbasso Helmers S, Ulfgren AK, Ronnblom L, Alm GV, Lundberg IE (2007) A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies. Arthritis Rheum 56:3112\u20133124","journal-title":"Arthritis Rheum"},{"key":"8527_CR89","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R et al (2005) Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57:664\u2013678","journal-title":"Ann Neurol"},{"key":"8527_CR90","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","volume":"35","author":"JM McNiff","year":"2008","unstructured":"McNiff JM, Kaplan DH (2008) Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus. J Cutan Pathol 35:452\u2013456","journal-title":"J Cutan Pathol"},{"key":"8527_CR91","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar4512","volume":"16","author":"M Yokota","year":"2014","unstructured":"Yokota M, Suzuki K, Tokoyoda K, Meguro K, Hosokawa J, Tanaka S et al (2014) Roles of mast cells in the pathogenesis of inflammatory myopathy. Arthritis Res Ther 16:R72","journal-title":"Arthritis Res Ther"},{"key":"8527_CR92","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/art.27529","volume":"62","author":"S Shrestha","year":"2010","unstructured":"Shrestha S, Wershil B, Sarwark JF, Niewold TB, Philipp T, Pachman LM (2010) Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum 62:2813\u20132822","journal-title":"Arthritis Rheum"},{"key":"8527_CR93","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2133.2005.06786.x","volume":"153","author":"J Wenzel","year":"2005","unstructured":"Wenzel J, Scheler M, Bieber T, Tuting T (2005) Evidence for a role of type I interferons in the pathogenesis of dermatomyositis. Br J Dermatol 153:462\u2013463, author reply 3\u20134","journal-title":"Br J Dermatol"},{"key":"8527_CR94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar3531","volume":"13","author":"EC Baechler","year":"2011","unstructured":"Baechler EC, Bilgic H, Reed AM (2011) Type I interferon pathway in adult and juvenile dermatomyositis. Arthritis Res Ther 13:249","journal-title":"Arthritis Res Ther"},{"key":"8527_CR95","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","volume":"60","author":"TB Niewold","year":"2009","unstructured":"Niewold TB, Kariuki SN, Morgan GA, Shrestha S, Pachman LM (2009) Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum 60:1815\u20131824","journal-title":"Arthritis Rheum"},{"key":"8527_CR96","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.2004.06144.x","volume":"151","author":"M Caproni","year":"2004","unstructured":"Caproni M, Torchia D, Cardinali C, Volpi W, Del Bianco E, D\u2019Agata A et al (2004) Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol 151:784\u2013791","journal-title":"Br J Dermatol"},{"key":"8527_CR97","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","volume":"73","author":"BW Higgs","year":"2014","unstructured":"Higgs BW, Zhu W, Morehouse C, White WI, Brohawn P, Guo X et al (2014) A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients. Ann Rheum Dis 73:256\u2013262","journal-title":"Ann Rheum Dis"},{"key":"8527_CR98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2011.05.013","volume":"11","author":"MC Dalakas","year":"2012","unstructured":"Dalakas MC (2012) Pathogenesis and therapies of immune-mediated myopathies. Autoimmun Rev 11:203\u2013206","journal-title":"Autoimmun Rev"},{"key":"8527_CR99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0046-8177(96)90132-X","volume":"27","author":"AN Crowson","year":"1996","unstructured":"Crowson AN, Magro CM (1996) The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 27:15\u201319","journal-title":"Hum Pathol"},{"key":"8527_CR100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","volume":"27","author":"AM Emslie-Smith","year":"1990","unstructured":"Emslie-Smith AM, Engel AG (1990) Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 27:343\u2013356","journal-title":"Ann Neurol"},{"key":"8527_CR101","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel JT, Mendell JR, Rammohan KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314:329\u2013334","journal-title":"N Engl J Med"},{"key":"8527_CR102","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"8527_CR103","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archderm.1995.01690240040007","volume":"131","author":"JM Mascaro Jr","year":"1995","unstructured":"Mascaro JM Jr, Hausmann G, Herrero C, Grau JM, Cid MC, Palou J et al (1995) Membrane attack complex deposits in cutaneous lesions of dermatomyositis. Arch Dermatol 131:1386\u20131392","journal-title":"Arch Dermatol"},{"key":"8527_CR104","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.10462","volume":"28","author":"D Figarella-Branger","year":"2003","unstructured":"Figarella-Branger D, Civatte M, Bartoli C, Pellissier JF (2003) Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 28:659\u2013682","journal-title":"Muscle Nerve"},{"key":"8527_CR105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/03009742.2014.956141","volume":"44","author":"A Notarnicola","year":"2015","unstructured":"Notarnicola A, Lapadula G, Natuzzi D, Lundberg IE, Iannone F (2015) Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies. Scand J Rheumatol 44:224\u2013228","journal-title":"Scand J Rheumatol"},{"key":"8527_CR106","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","volume":"40","author":"I Lundberg","year":"1997","unstructured":"Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L (1997) Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 40:865\u2013874","journal-title":"Arthritis Rheum"},{"key":"8527_CR107","doi-asserted-by":"crossref","first-page":"472624","DOI":"10.1155\/2014\/472624","volume":"2014","author":"A Tournadre","year":"2014","unstructured":"Tournadre A, Dubost JJ, Soubrier M, Ruivard M, Souteyrand P, Schmidt J et al (2014) Soluble IL-2 receptor: a biomarker for assessing myositis activity. Dis Markers 2014:472624","journal-title":"Dis Markers"},{"key":"8527_CR108","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","volume":"53","author":"T Gono","year":"2014","unstructured":"Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M et al (2014) Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatol (Oxford, England) 53:2196\u20132203","journal-title":"Rheumatol (Oxford, England)"},{"key":"8527_CR109","doi-asserted-by":"crossref","first-page":"815245","DOI":"10.1155\/2014\/815245","volume":"2014","author":"H Kawasumi","year":"2014","unstructured":"Kawasumi H, Gono T, Kawaguchi Y, Kaneko H, Katsumata Y, Hanaoka M et al (2014) IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis\/dermatomyositis. BioMed Res Int 2014:815245","journal-title":"BioMed Res Int"},{"key":"8527_CR110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00296-010-1692-y","volume":"32","author":"P Mielnik","year":"2012","unstructured":"Mielnik P, Chwalinska-Sadowska H, Wiesik-Szewczyk E, Maslinski W, Olesinska M (2012) Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity. Rheumatol Int 32:639\u2013643","journal-title":"Rheumatol Int"},{"key":"8527_CR111","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.nmd.2014.06.432","volume":"24","author":"EM Moran","year":"2014","unstructured":"Moran EM, Mastaglia FL (2014) The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications. Neuromuscul Disord 24:943\u2013952","journal-title":"Neuromuscul Disord"},{"key":"8527_CR112","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2006.03180.x","volume":"146","author":"M Tucci","year":"2006","unstructured":"Tucci M, Quatraro C, Dammacco F, Silvestris F (2006) Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies. Clin Exp Immunol 146:21\u201331","journal-title":"Clin Exp Immunol"},{"key":"8527_CR113","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/rheumatology\/keu005","volume":"53","author":"F Ciccia","year":"2014","unstructured":"Ciccia F, Rizzo A, Alessandro R, Guggino G, Maugeri R, Saieva L et al (2014) Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity. Rheumatol (Oxford, England) 53:1307\u20131312","journal-title":"Rheumatol (Oxford, England)"},{"key":"8527_CR114","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2010.517215","volume":"40","author":"H Shen","year":"2011","unstructured":"Shen H, Xia L, Lu J, Xiao W (2011) Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis. Scand J Rheumatol 40:217\u2013220","journal-title":"Scand J Rheumatol"},{"key":"8527_CR115","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","volume":"70","author":"AP Liao","year":"2011","unstructured":"Liao AP, Salajegheh M, Nazareno R, Kagan JC, Jubin RG, Greenberg SA (2011) Interferon beta is associated with type 1 interferon-inducible gene expression in dermatomyositis. Ann Rheum Dis 70:831\u2013836","journal-title":"Ann Rheum Dis"},{"key":"8527_CR116","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cei.12445","volume":"178","author":"EM Moran","year":"2014","unstructured":"Moran EM, Mastaglia FL (2014) Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications. Clin Exp Immunol 178:405\u2013415","journal-title":"Clin Exp Immunol"},{"key":"8527_CR117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0140","volume":"2","author":"MC Dalakas","year":"2006","unstructured":"Dalakas MC (2006) Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract 2:219\u2013227","journal-title":"Nat Clin Pract"},{"key":"8527_CR118","first-page":"e56","volume":"166","author":"F Limongi","year":"2015","unstructured":"Limongi F (2015) The CXCR3 chemokines in inflammatory myopathies. La Clin Terapeutica 166:e56\u2013e61","journal-title":"La Clin Terapeutica"},{"key":"8527_CR119","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejcb.2011.09.011","volume":"91","author":"C Crescioli","year":"2012","unstructured":"Crescioli C, Sottili M, Bonini P, Cosmi L, Chiarugi P, Romagnani P et al (2012) Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. Eur J Cell Biol 91:139\u2013149","journal-title":"Eur J Cell Biol"},{"key":"8527_CR120","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/art.22521","volume":"56","author":"T Sugihara","year":"2007","unstructured":"Sugihara T, Sekine C, Nakae T, Kohyama K, Harigai M, Iwakura Y et al (2007) A new murine model to define the critical pathologic and therapeutic mediators of polymyositis. Arthritis Rheum 56:1304\u20131314","journal-title":"Arthritis Rheum"},{"key":"8527_CR121","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1002\/art.27625","volume":"62","author":"T Sugihara","year":"2010","unstructured":"Sugihara T, Okiyama N, Suzuki M, Kohyama K, Matsumoto Y, Miyasaka N et al (2010) Definitive engagement of cytotoxic CD8 T cells in C protein-induced myositis, a murine model of polymyositis. Arthritis Rheum 62:3088\u20133092","journal-title":"Arthritis Rheum"},{"key":"8527_CR122","first-page":"780","volume":"146","author":"R Klein","year":"2010","unstructured":"Klein R, Rosenbach M, Kim EJ, Kim B, Werth VP, Dunham J (2010) Tumor necrosis factor inhibitor-associated dermatomyositis. Arch Dermatol 146:780\u2013784","journal-title":"Arch Dermatol"},{"key":"8527_CR123","doi-asserted-by":"crossref","first-page":"e92171","DOI":"10.1371\/journal.pone.0092171","volume":"9","author":"H Sanner","year":"2014","unstructured":"Sanner H, Schwartz T, Flato B, Vistnes M, Christensen G, Sjaastad I (2014) Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage. PLoS One 9:e92171","journal-title":"PLoS One"},{"key":"8527_CR124","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/ar3761","volume":"14","author":"F Suzuki","year":"2012","unstructured":"Suzuki F, Kubota T, Miyazaki Y, Ishikawa K, Ebisawa M, Hirohata S et al (2012) Serum level of soluble CX3CL1\/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity. Arthritis Res Ther 14:R48","journal-title":"Arthritis Res Ther"},{"key":"8527_CR125","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","volume":"181","author":"C Preusse","year":"2012","unstructured":"Preusse C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K et al (2012) Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile. Am J Pathol 181:2161\u20132171","journal-title":"Am J Pathol"},{"key":"8527_CR126","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","volume":"21","author":"B Paepe De","year":"2009","unstructured":"De Paepe B, Creus KK, De Bleecker JL (2009) Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol 21:610\u2013616","journal-title":"Curr Opin Rheumatol"},{"key":"8527_CR127","first-page":"e118","volume":"166","author":"G Elia","year":"2015","unstructured":"Elia G (2015) Dermatomyositis and chemokines. La Clin Terapeutica 166:e118\u2013e121","journal-title":"La Clin Terapeutica"},{"key":"8527_CR128","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamadermatol.2013.5220","volume":"149","author":"SW Liu","year":"2013","unstructured":"Liu SW, Velez NF, Lam C, Femia A, Granter SR, Townsend HB et al (2013) Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis. JAMA Dermatol 149:1204\u20131208","journal-title":"JAMA Dermatol"},{"key":"8527_CR129","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2008.10.060","volume":"61","author":"AE Moustou","year":"2009","unstructured":"Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ (2009) Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol 61:486\u2013504","journal-title":"J Am Acad Dermatol"},{"key":"8527_CR130","first-page":"192","volume":"39","author":"G Riolo","year":"2012","unstructured":"Riolo G, Towheed TE (2012) Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis. J Rheumatol 39:192\u2013194","journal-title":"J Rheumatol"},{"key":"8527_CR131","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.22358","volume":"55","author":"HA Hall","year":"2006","unstructured":"Hall HA, Zimmermann B (2006) Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor. Arthritis Rheum 55:982\u2013984","journal-title":"Arthritis Rheum"},{"key":"8527_CR132","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-009-1370-1","volume":"29","author":"Y Ishikawa","year":"2010","unstructured":"Ishikawa Y, Yukawa N, Ohmura K, Hosono Y, Imura Y, Kawabata D et al (2010) Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Rheumatol 29:563\u2013566","journal-title":"Clin Rheumatol"},{"key":"8527_CR133","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/keg388","volume":"42","author":"J Musial","year":"2003","unstructured":"Musial J, Undas A, Celinska-Lowenhoff M (2003) Polymyositis associated with infliximab treatment for rheumatoid arthritis. Rheumatol (Oxford, England) 42:1566\u20131568","journal-title":"Rheumatol (Oxford, England)"},{"key":"8527_CR134","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/s10165-006-0523-1","volume":"16","author":"Y Urata","year":"2006","unstructured":"Urata Y, Wakai Y, Kowatari K, Nitobe T, Mizushima Y (2006) Polymyositis associated with infliximab treatment for rheumatoid arthritis. Modern Rheumatol Jpn Rheumat Assoc 16:410\u2013411","journal-title":"Modern Rheumatol Jpn Rheumat Assoc"},{"key":"8527_CR135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-010-1666-1","volume":"30","author":"Y Ishikawa","year":"2011","unstructured":"Ishikawa Y, Yukawa N, Kawabata D, Ohmura K, Fujii T, Usui T et al (2011) A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept. Clin Rheumatol 30:429\u2013432","journal-title":"Clin Rheumatol"},{"key":"8527_CR136","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/rheumatology\/ket279","volume":"53","author":"P Venalis","year":"2014","unstructured":"Venalis P, Lundberg IE (2014) Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatol (Oxford, England) 53:397\u2013405","journal-title":"Rheumatol (Oxford, England)"},{"key":"8527_CR137","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11926-009-0041-1","volume":"11","author":"AM Reed","year":"2009","unstructured":"Reed AM, Ernste F (2009) The inflammatory milieu in idiopathic inflammatory myositis. Curr Rheumatol Rep 11:295\u2013301","journal-title":"Curr Rheumatol Rep"},{"key":"8527_CR138","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/rheumatology\/keq151","volume":"49","author":"P Szodoray","year":"2010","unstructured":"Szodoray P, Alex P, Knowlton N, Centola M, Dozmorov I, Csipo I et al (2010) Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand. Rheumatol (Oxford, England) 49:1867\u20131877","journal-title":"Rheumatol (Oxford, England)"},{"key":"8527_CR139","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/j.lpm.2010.12.013","volume":"40","author":"RK Gherardi","year":"2011","unstructured":"Gherardi RK (2011) Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis. Presse Med 40:e209\u2013e218","journal-title":"Presse Med"},{"key":"8527_CR140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00019052-200406000-00018","volume":"17","author":"SA Greenberg","year":"2004","unstructured":"Greenberg SA, Amato AA (2004) Uncertainties in the pathogenesis of adult dermatomyositis. Curr Opin Neurol 17:359\u2013364","journal-title":"Curr Opin Neurol"},{"key":"8527_CR141","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9440(10)62513-8","volume":"159","author":"P Englund","year":"2001","unstructured":"Englund P, Lindroos E, Nennesmo I, Klareskog L, Lundberg IE (2001) Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am J Pathol 159:1263\u20131273","journal-title":"Am J Pathol"},{"key":"8527_CR142","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1002\/art.27665","volume":"62","author":"JM Pandya","year":"2010","unstructured":"Pandya JM, Fasth AE, Zong M, Arnardottir S, Dani L, Lindroos E et al (2010) Expanded T cell receptor Vbeta-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis Rheum 62:3457\u20133466","journal-title":"Arthritis Rheum"},{"key":"8527_CR143","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/08916930802282651","volume":"42","author":"L Banica","year":"2009","unstructured":"Banica L, Besliu A, Pistol G, Stavaru C, Ionescu R, Forsea AM et al (2009) Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 42:41\u201349","journal-title":"Autoimmunity"},{"key":"8527_CR144","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","volume":"16","author":"K Arahata","year":"1984","unstructured":"Arahata K, Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16:193\u2013208","journal-title":"Ann Neurol"},{"key":"8527_CR145","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10067-012-2075-4","volume":"31","author":"DX Wang","year":"2012","unstructured":"Wang DX, Lu X, Zu N, Lin B, Wang LY, Shu XM et al (2012) Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis. Clin Rheumatol 31:1691\u20131697","journal-title":"Clin Rheumatol"},{"key":"8527_CR146","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","volume":"65","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA, Bradshaw EM, Pinkus JL, Pinkus GS, Burleson T, Due B et al (2005) Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 65:1782\u20131787","journal-title":"Neurology"},{"key":"8527_CR147","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","volume":"178","author":"EM Bradshaw","year":"2007","unstructured":"Bradshaw EM, Orihuela A, McArdel SL, Salajegheh M, Amato AA, Hafler DA et al (2007) A local antigen-driven humoral response is present in the inflammatory myopathies. J Immunol 178:547\u2013556","journal-title":"J Immunol"},{"key":"8527_CR148","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","volume":"249","author":"A Baek","year":"2012","unstructured":"Baek A, Park HJ, Na SJ, Shim DS, Moon JS, Yang Y et al (2012) The expression of BAFF in the muscles of patients with dermatomyositis. J Neuroimmunol 249:96\u2013100","journal-title":"J Neuroimmunol"},{"key":"8527_CR149","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2008.091405","volume":"68","author":"O Krystufkova","year":"2009","unstructured":"Krystufkova O, Vallerskog T, Helmers SB, Mann H, Putova I, Belacek J et al (2009) Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis 68:836\u2013843","journal-title":"Ann Rheum Dis"},{"key":"8527_CR150","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/rheumatology\/ker305","volume":"50","author":"M Couderc","year":"2011","unstructured":"Couderc M, Gottenberg JE, Mariette X, Hachulla E, Sibilia J, Fain O et al (2011) Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. Rheumatol (Oxford, England) 50:2283\u20132289","journal-title":"Rheumatol (Oxford, England)"},{"key":"8527_CR151","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1111\/j.1445-5994.2011.02702.x","volume":"42","author":"V Limaye","year":"2012","unstructured":"Limaye V, Hissaria P, Liew CL, Koszyka B (2012) Efficacy of rituximab in refractory antisynthetase syndrome. Int Med J 42:e4\u2013e7","journal-title":"Int Med J"},{"key":"8527_CR152","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314\u2013324","journal-title":"Arthritis Rheum"},{"key":"8527_CR153","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","volume":"9","author":"IN Targoff","year":"1997","unstructured":"Targoff IN, Miller FW, Medsger TA Jr, Oddis CV (1997) Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 9:527\u2013535","journal-title":"Curr Opin Rheumatol"},{"key":"8527_CR154","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s11926-996-0025-3","volume":"8","author":"IN Targoff","year":"2006","unstructured":"Targoff IN (2006) Myositis specific autoantibodies. Curr Rheumatol Rep 8:196\u2013203","journal-title":"Curr Rheumatol Rep"},{"key":"8527_CR155","first-page":"891","volume":"32","author":"A Ceribelli","year":"2014","unstructured":"Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Tincani A, Selmi C et al (2014) Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis. Clin Exp Rheumatol 32:891\u2013897","journal-title":"Clin Exp Rheumatol"},{"key":"8527_CR156","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","volume":"14","author":"A Ceribelli","year":"2012","unstructured":"Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Franceschini F, Quinzanini M et al (2012) Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis. Arthritis Res Ther 14:R97","journal-title":"Arthritis Res Ther"},{"key":"8527_CR157","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1212\/NXI.0000000000000096","volume":"2","author":"S Ramanathan","year":"2015","unstructured":"Ramanathan S, Langguth D, Hardy TA, Garg N, Bundell C, Rojana-Udomsart A et al (2015) Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy. Neurol (R) Neuroimmunol Neuroinflammation 2:e96","journal-title":"Neurol (R) Neuroimmunol Neuroinflammation"},{"key":"8527_CR158","first-page":"297","volume":"7","author":"M Zong","year":"2011","unstructured":"Zong M, Lundberg IE (2011) Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev 7:297\u2013306","journal-title":"Nat Rev"},{"key":"8527_CR159","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0046-8177(92)90400-W","volume":"23","author":"R Estruch","year":"1992","unstructured":"Estruch R, Grau JM, Fernandez-Sola J, Casademont J, Monforte R, Urbano-Marquez A (1992) Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 23:888\u2013895","journal-title":"Hum Pathol"},{"key":"8527_CR160","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.23884","volume":"58","author":"C Grundtman","year":"2008","unstructured":"Grundtman C, Tham E, Ulfgren AK, Lundberg IE (2008) Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum 58:3224\u20133238","journal-title":"Arthritis Rheum"},{"key":"8527_CR161","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nmd.2010.01.005","volume":"20","author":"S Probst-Cousin","year":"2010","unstructured":"Probst-Cousin S, Neundorfer B, Heuss D (2010) Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors. Neuromuscul Disord 20:192\u2013197","journal-title":"Neuromuscul Disord"},{"key":"8527_CR162","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/art.1780380111","volume":"38","author":"JH Park","year":"1995","unstructured":"Park JH, Olsen NJ, King L Jr, Vital T, Buse R, Kari S et al (1995) Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 38:68\u201377","journal-title":"Arthritis Rheum"},{"key":"8527_CR163","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/art.23729","volume":"58","author":"T Hamada","year":"2008","unstructured":"Hamada T, Torikai M, Kuwazuru A, Tanaka M, Horai N, Fukuda T et al (2008) Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. Arthritis Rheum 58:2675\u20132685","journal-title":"Arthritis Rheum"},{"key":"8527_CR164","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.20220","volume":"50","author":"AK Ulfgren","year":"2004","unstructured":"Ulfgren AK, Grundtman C, Borg K, Alexanderson H, Andersson U, Harris HE et al (2004) Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum 50:1586\u20131594","journal-title":"Arthritis Rheum"},{"key":"8527_CR165","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1096\/fj.09-144782","volume":"24","author":"C Grundtman","year":"2010","unstructured":"Grundtman C, Bruton J, Yamada T, Ostberg T, Pisetsky DS, Harris HE et al (2010) Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. Faseb J 24:570\u2013578","journal-title":"Faseb J"},{"key":"8527_CR166","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nrd2755","volume":"7","author":"I Kim","year":"2008","unstructured":"Kim I, Xu W, Reed JC (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7:1013\u20131030","journal-title":"Nat Rev Drug Discov"},{"key":"8527_CR167","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/BOR.0b013e3283319265","volume":"21","author":"A Henriques-Pons","year":"2009","unstructured":"Henriques-Pons A, Nagaraju K (2009) Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis. Curr Opin Rheumatol 21:581\u2013587","journal-title":"Curr Opin Rheumatol"},{"key":"8527_CR168","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2353\/ajpath.2009.090196","volume":"175","author":"CK Li","year":"2009","unstructured":"Li CK, Knopp P, Moncrieffe H, Singh B, Shah S, Nagaraju K et al (2009) Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis. Am J Pathol 175:1030\u20131040","journal-title":"Am J Pathol"},{"key":"8527_CR169","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","volume":"19","author":"V Askanas","year":"2009","unstructured":"Askanas V, Engel WK, Nogalska A (2009) Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol (Zurich, Switzerland) 19:493\u2013506","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"key":"8527_CR170","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.neurobiolaging.2008.11.003","volume":"31","author":"A Shtifman","year":"2010","unstructured":"Shtifman A, Ward CW, Laver DR, Bannister ML, Lopez JR, Kitazawa M et al (2010) Amyloid-beta protein impairs Ca2+ release and contractility in skeletal muscle. Neurobiol Aging 31:2080\u20132090","journal-title":"Neurobiol Aging"},{"key":"8527_CR171","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","volume":"278","author":"P Temiz","year":"2009","unstructured":"Temiz P, Weihl CC, Pestronk A (2009) Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci 278:25\u201329","journal-title":"J Neurol Sci"},{"key":"8527_CR172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111490","volume":"9","author":"C Cappelletti","year":"2014","unstructured":"Cappelletti C, Galbardi B, Kapetis D, Vattemi G, Guglielmi V, Tonin P et al (2014) Autophagy, inflammation and innate immunity in inflammatory myopathies. PLoS One 9, e111490","journal-title":"PLoS One"},{"key":"8527_CR173","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","volume":"23","author":"A Pestronk","year":"2011","unstructured":"Pestronk A (2011) Acquired immune and inflammatory myopathies: pathologic classification. Curr Opin Rheumatol 23:595\u2013604","journal-title":"Curr Opin Rheumatol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-016-8527-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8527-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:17:00Z","timestamp":1567538220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-016-8527-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,16]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["8527"],"URL":"https:\/\/doi.org\/10.1007\/s12016-016-8527-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,16]]}}}